查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1792317

2025 年至 2033 年幹細胞銀行市場報告（按產品類型、服務類型、銀行類型、使用率、應用和地區分類）

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球幹細胞庫市場規模達86億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到155億美元，2025-2033年期間的複合年成長率（CAGR）為6.48%。幹細胞分離、儲存和運輸技術的不斷進步、醫療保健支出的不斷成長、再生醫學的不斷進步以及私營企業的大量投資，都是推動市場發展的一些因素。

幹細胞庫是一項革命性的醫學進步，為未來提供了一條生命線。這個過程涉及保存來自各種來源的幹細胞，例如臍帶血或成人組織。這些細胞擁有非凡的再生潛力，是治療多種疾病的關鍵，從白血病到帕金森氏症等神經退化性疾病。幹細胞庫透過超低溫冷凍來保護這些生物寶藏，確保其數十年的活力。其意義深遠。家庭可以獲得一份生物保險，因為這些細胞可以治療捐贈者和基因相容的親屬，從而降低免疫排斥的風險。此外，幹細胞研究不斷揭示新的治療應用，並有望在個人化醫療方面取得突破。然而，幹細胞庫的可及性仍然是一個問題，全球各地的成本和認知度各不相同。幹細胞庫是一項富有遠見的健康投資。它可以開啟一個未來，即用患者的細胞治療令人衰弱的疾病，消除高風險的移植需求，並開闢醫學科學的新領域。擴大對這項變革性技術的使用範圍和認知對於充分發揮其潛力造福人類至關重要。

全球市場的主要驅動力在於，人們日益意識到幹細胞在治療多種疾病（包括癌症、糖尿病和心血管疾病）方面的治療潛力。大量的研究和臨床試驗不斷證明幹細胞療法的有效性，激發了醫療專業人士和公眾的熱情，進一步增強了人們的認知。此外，隨著越來越多的夫婦選擇晚育，延後生育的趨勢日益盛行，這也加劇了人們對臍帶血庫的興趣。父母們認知到，保存新生兒臍帶血幹細胞，可以作為未來子女或家庭成員面臨醫療挑戰時的生物保險。此外，幹細胞庫服務的全球化也是另一個關鍵驅動力。冷凍保存技術的進步延長了幹細胞的保存期限，使其能夠進行國際運輸和跨境使用。這擴大了市場覆蓋範圍，並促進了幹細胞庫之間的全球合作。此外，政府的支持和監管框架也越來越有利於幹細胞庫的發展，為投資和成長創造了良好的環境。慢性病的日益普及以及幹細胞提供個人化治療的潛力鞏固了其作為未來醫療保健關鍵組成部分的地位，確保了市場的持續擴張。

幹細胞庫市場趨勢/促進因素：

人口老化加劇

人口老化日益加劇，對市場產生了正面影響。這種人口結構的變化正在改變全球醫療保健格局。隨著年齡的成長，人們更容易患上退化性疾病，例如骨關節炎、心血管疾病以及阿茲海默症和帕金森氏症等神經退化性疾病。幹細胞在再生受損或老化組織方面擁有巨大的潛力，有望帶來突破性的治療方法，並提高老年人的生活品質。不斷成長的老齡人口需要更先進的醫療保健解決方案，這也為幹細胞庫服務帶來了龐大的客戶群。許多個人和家庭都認知到保存自己或親人幹細胞的潛力，這些幹細胞來自臍帶血或脂肪組織等來源。這些儲存的幹細胞可用於未來的治療，以對抗與年齡相關的健康問題，從而帶來安全感和樂觀感。因此，老齡人口對幹細胞再生潛力的認知不斷提高，加上他們對改善醫療保健選擇的渴望，成為幹細胞銀行服務需求不斷成長的驅動力，為未來幾年市場持續成長奠定了基礎。

臨床試驗的接受度不斷提高

臨床試驗日益普及，正在催化市場發展。臨床試驗對於證明幹細胞療法在治療各種疾病（從癌症到脊髓損傷）的安全性和有效性至關重要。隨著這些試驗結果持續展現出良好的前景，醫療專業人員、研究人員和公眾對幹細胞療法的信心也日益增強。這種日益普及的接受度轉化為對幹細胞庫服務的需求成長。臨床試驗通常需要易於取得且可靠的高品質幹細胞來源，而專門儲存這些細胞的幹細胞庫恰好滿足了這個關鍵需求。研究人員和製藥公司依靠這些幹細胞庫提供試驗所需的標準化且保存完好的幹細胞樣本，從而推動了市場的成長。此外，臨床試驗的積極成果推動了再生醫學領域的發展，並吸引了公共和私營部門的投資，促進了創新，並擴大了幹細胞庫服務的範圍。這種研究、普及和投資的良性循環推動著市場的發展。

圍繞胚胎幹細胞使用的倫理擔憂日益加劇

圍繞胚胎幹細胞使用的倫理擔憂日益加劇，這正在推動市場發展。長期以來，由於破壞胚胎，胚胎幹細胞研究一直是倫理爭議的焦點，並在許多地區導致道德和監管限制。這使得幹細胞研究和治療應用的重點轉向了無爭議的來源，例如成體幹細胞和臍帶血。因此，尋求幹細胞療法潛在益處且無需承擔倫理責任的個人和機構紛紛轉向幹細胞庫。尤其是臍帶血，因其豐富的幹細胞來源而備受矚目，且不存在任何倫理問題。家庭和醫療保健提供者認知到保存這些細胞的價值，將其作為對捐贈者和潛在匹配家庭成員未來疾病的生物保險。這種向符合倫理道德的幹細胞來源的轉變與大多數幹細胞庫的做法相一致，從而吸引了更廣泛的客戶群，並促進了該行業的發展。隨著倫理考量持續影響公眾輿論和監管決策，市場已準備好持續擴張。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球幹細胞銀行市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場區隔：依產品類型
  • 市場區隔：依服務類型
  • 市場區隔：依銀行類型
  • 市場區隔：依用途
  • 市場區隔：按應用
  • 市場區隔：按地區
  • 市場預測

第6章：市場區隔：依產品類型

  • 成體幹細胞
  • 人類胚胎細胞
  • IPS細胞

第7章：市場區隔：依服務類型

  • 樣品保存與儲存
  • 樣品分析
  • 樣品處理
  • 樣本採集與運輸

第8章：市場區隔：依銀行類型

  • 私人的
  • 民眾

第9章：市場區隔：按利用率

  • 用過的
  • 未使用

第10章：市場細分：按應用

  • 個性化銀行應用程式
  • 研究應用
  • 臨床應用

第 11 章：市場區隔：按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第 12 章：全球幹細胞庫產業：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第13章：全球幹細胞庫產業：價值鏈分析

第 14 章：全球幹細胞庫產業：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：全球幹細胞庫產業：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • CBR Systems Inc.
    • China Cord Blood Corporation
    • Cordlife
    • Cordvida
    • Cryo-Cell International, Inc.
    • Cryo-Save AG (A Group of Esperite)
    • Cryoviva India
    • Lifecell
    • Smart Cells International Ltd
    • Viacord
Product Code: SR112025A1152

The global stem cell banking market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.48% during 2025-2033. The increasing improvements in stem cell isolation, storage, and transportation technologies, the rising healthcare expenditure, the growing progress in regenerative medicine, and the heavy investments by private companies are some of the factors propelling the market.

Stem cell banking, a revolutionary medical advancement, offers a lifeline for the future. This process involves preserving stem cells from various sources, such as umbilical cord blood or adult tissues. These cells possess remarkable regenerative potential, holding the key to treating multiple diseases, from leukemia to neurodegenerative conditions like Parkinson's. Stem cell banking safeguards these biological treasures by cryogenically freezing them at ultra-low temperatures, ensuring their viability for decades. The implications are profound. Families can secure a biological insurance policy, as these cells can treat the donor and genetically compatible relatives, reducing the risk of immune rejection. Additionally, stem cell research continues to unveil new therapeutic applications, promising breakthroughs in personalized medicine. However, accessibility remains an issue, with costs and awareness varying globally. Stem cell banking is a visionary investment in health. It can unlock a future where debilitating diseases are treated with the patient's cells, eliminating the need for risky transplants and opening new frontiers in medical science. Expanding access and awareness of this transformative technology is essential to harness its full potential for the benefit of humanity.

The global market is majorly driven by increasing awareness of the therapeutic potential of stem cells in treating a wide array of diseases, including cancer, diabetes, and cardiovascular conditions. This heightened awareness is fueled by extensive research and clinical trials that continually demonstrate the efficacy of stem cell-based therapies, capturing the imagination of medical professionals and the general public. Furthermore, the expanding trend of delayed parenthood, with more couples opting to have children later in life, has intensified interest in umbilical cord blood banking. Parents recognize the value of preserving their newborn's cord blood stem cells as biological insurance should their child or a family member face a future medical challenge. Moreover, the globalization of stem cell banking services is another key driver. Advances in cryopreservation techniques have extended the shelf life of stored stem cells, allowing for international transportation and cross-border utilization. This has widened the market's reach and fostered worldwide collaboration among stem cell banks. Additionally, government support and regulatory frameworks are becoming more conducive to stem cell banking, fostering a favorable environment for investment and growth. The increasing prevalence of chronic diseases and the potential of stem cells to provide personalized treatments solidifies its position as a pivotal component of future healthcare, ensuring the market's continued expansion.

Stem Cell Banking Market Trends/Drivers:

Increasing aging population

The increasing aging population is positively influencing the market. This demographic shift is transforming healthcare dynamics globally. As individuals age, they become more susceptible to degenerative diseases such as Osteoarthritis, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's and Parkinson's. Stem cells hold immense promise in regenerating damaged or aging tissues, offering the potential for groundbreaking treatments and enhanced quality of life for older people. This growing elderly population demands more advanced healthcare solutions and represents a substantial customer base for stem cell banking services. Several individuals and families recognize the potential of preserving their or their loved ones' stem cells, harvested from sources like cord blood or adipose tissue. These stored stem cells can be used in future therapies to combat age-related health issues, creating a sense of security and optimism. As a result, the aging population's increasing awareness of the regenerative potential of stem cells, coupled with their desire for improved healthcare options, is a driving force behind the rising demand for stem cell banking services, positioning the market for sustained growth in the years to come.

Rising acceptance of clinical trials

The rising acceptance of clinical trials is catalyzing the market. Clinical trials are pivotal in demonstrating the safety and efficacy of stem cell-based therapies across various medical conditions, ranging from cancer to spinal cord injuries. As the results of these trials continue to show promise, confidence in stem cell-based treatments is bolstered among medical professionals, researchers, and the general public. This increasing acceptance translates into greater demand for stem cell banking services. Clinical trials often require a readily accessible and reliable source of high-quality stem cells, and banks specializing in storing these cells meet this critical need. Researchers and pharmaceutical companies rely on these banks to provide the standardized and well-preserved stem cell samples required for their trials, thus driving the market's growth. Furthermore, positive outcomes from clinical trials advance the regenerative medicine field and attract investments from both the public and private sectors, fostering innovation and expanding the range of stem cell banking services available. This virtuous cycle of research, acceptance, and investment propels the market.

Escalating ethical concerns surrounding the use of embryonic stem cells

The escalating ethical concerns surrounding the use of embryonic stem cells are bolstering the market. Embryonic stem cell research has long been a subject of ethical debate due to destroying embryos, resulting in moral and regulatory restrictions in many regions. This has shifted the focus of stem cell research and therapeutic applications towards non-controversial sources, such as adult stem cells and cord blood. As a result, individuals and institutions seeking the potential benefits of stem cell therapies without ethical quandaries are turning to stem cell banking. Cord blood, in particular, has gained prominence as a rich source of stem cells without any ethical concerns. Families and healthcare providers recognize the value of preserving these cells as biological insurance against future illnesses for the donor and potentially compatible family members. This shift towards ethically sound stem cell sources aligns with the practices of most stem cell banks, attracting a broader customer base and contributing to the industry's growth. The market is well-positioned for sustained expansion as ethical considerations continue influencing public opinion and regulatory decisions.

Stem Cell Banking Industry Segmentation:

Breakup by Product Type:

  • Adult Stem Cells
  • Human Embryonic Cells
  • IPS Cells

Adult stem cells dominate the market

Adult stem cells, also known as somatic or tissue-specific, have emerged as a game-changer in regenerative medicine. These cells are ethically uncontroversial, sourced from bone marrow, adipose tissue, and peripheral blood. Their therapeutic potential in treating various ailments, including orthopedic issues, cardiovascular diseases, and autoimmune disorders, is increasingly recognized.

The rising demand for adult stem cell banking services stems from the growing awareness of their versatility and effectiveness. Patients, physicians, and researchers are considering preserving adult stem cells as a proactive approach to future medical challenges. This demand drives competition and innovation within the industry, resulting in improved storage techniques and expanded service offerings. As regenerative medicine continues to advance, the adult stem cell segment stands as a linchpin in the market's overall expansion, promising personalized healthcare solutions for various conditions and securing its position at the forefront of medical progress.

Breakup by Service Type:

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

Sample preservation and storage dominate the market

Sample preservation and storage segment plays a pivotal role in propelling the market. Stem cell therapies have emerged as a revolutionary medical frontier, promising treatments for various diseases and conditions. Consequently, the demand for safe and reliable storage solutions for precious stem cell samples has skyrocketed. These services offered by stem cell banks ensure these valuable biological assets' long-term viability and potency. This crucial service segment encompasses cutting-edge cryopreservation techniques, state-of-the-art storage facilities, and rigorous quality control measures.

In an era where regenerative medicine is gaining prominence, the efficacy of stem cell treatments hinges on the integrity and accessibility of stored samples. The commitment of stem cell banks to maintaining optimal sample conditions instills confidence in healthcare providers and encourages individuals to invest in stem cell banking for their future medical needs. This rising demand for Sample Preservation and Storage services drives the revenue growth of stem cell banks and fuels advancements in biotechnology and medical research, ultimately paving the way for innovative therapies and improved healthcare outcomes.

Breakup by Bank Type:

  • Private
  • Public

Private dominates the market

Private stem cell banks cater to the growing trend of individuals and families taking proactive measures to secure their health and that of their loved ones. These banks offer a unique opportunity for clients to preserve their own or their newborn's stem cells, often sourced from cord blood, for potential future medical needs. This personalized approach to healthcare resonates strongly with a wide demographic, ranging from expectant parents seeking to secure their child's health to adults considering their long-term well-being.

The appeal of private stem cell banks lies in the assurance of access and control over one's biological assets a sense of biological insurance. As medical research unveils novel therapies and applications for stem cells, private banks' convenience and peace of mind are significant drivers of market growth. This segment's emphasis on personalized healthcare aligns with the evolving healthcare landscape, cementing its role in shaping the future of medicine and propelling market growth.

Breakup by Utilization:

  • Used
  • Unused

Unused dominates the market

The unused segment is equally influential, especially with the growing trend toward proactive healthcare. Individuals and families recognize the intrinsic value of preserving stem cells for potential future use, even without immediate medical need. This preventive approach is reinforced by ongoing research revealing new applications for stem cells. The prospect of securing biological insurance against unforeseen health challenges or benefiting from emerging therapies amplifies the demand for stem cell banking services, further solidifying its position as a dynamic force in modern healthcare.

Furthermore, the used segment reflects the escalating clinical adoption of stem cell-based therapies and treatments, spanning various medical conditions from leukemia to spinal cord injuries. As the effectiveness and safety of these therapies become increasingly established through clinical trials and real-world applications, the demand for access to stored stem cell samples surges. This drives the growth of stem cell banking services as patients and healthcare providers seek reliable sources for viable and high-quality stem cells.

Breakup by Application:

  • Personalized Banking Applications
  • Research Applications
  • Clinical Applications

Clinical applications dominate the market

Stem cells hold immense potential in regenerative medicine, and clinical applications harness this potential to treat various medical conditions. From neurological disorders like Parkinson's and Alzheimer's to orthopedic injuries and autoimmune diseases, stem cell-based therapies offer new hope for patients worldwide. The availability of well-preserved and diverse stem cell samples from banks is paramount for successful clinical interventions.

Clinical applications encompass established treatments and cutting-edge therapies in various stages of development, including clinical trials. These applications demand various stem cell types, such as hematopoietic, mesenchymal, and induced pluripotent stem cells, each tailored to specific medical needs. Stem cell banks offering a comprehensive array of these resources contribute significantly to the growth of clinical applications in regenerative medicine.

Furthermore, as research expands our understanding of stem cell biology and therapeutic potential, the clinical landscape is poised for continuous evolution. Consequently, the Clinical Applications segment remains a key driver in the stem cell banking market, fostering innovation and offering renewed optimism for patients seeking novel treatments and improved healthcare outcomes.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America plays a pivotal role in driving the growth of the market. With its advanced healthcare infrastructure, robust research and development activities, and a population increasingly aware of the potential benefits of stem cell therapies, the region stands at the forefront of this burgeoning industry. In the region, stem cell banking is viewed as a proactive health measure and a source of hope for patients suffering from a range of debilitating conditions.

In particular, the United States and Canada have witnessed significant investments in private stem cell banks driven by a combination of healthcare advancements and a culture of health-consciousness. Furthermore, the region's regulatory environment has been relatively supportive, further bolstering market growth by fostering a favorable climate for stem cell banking services.

As clinical trials for stem cell-based therapies expand, and research endeavors continue to flourish in North America, the demand for high-quality stem cell preservation and banking services continues to rise, making this region a powerhouse in shaping the future of stem cell banking.

Competitive Landscape:

Top companies are pivotal in strengthening market growth through a multifaceted approach. These industry leaders invest heavily in cutting-edge research and development, driving innovation in stem cell preservation and analysis techniques. They continually enhance the quality and viability of stored stem cells, instilling confidence in their clients and the medical community. These companies also prioritize extensive collaborations with research institutions, pharmaceutical firms, and healthcare providers. This collaborative spirit fosters the advancement of stem cell-based therapies, expanding their applications and creating a growing demand for banking services. Moreover, top firms actively engage in public awareness campaigns, educating individuals and families about the potential benefits of stem cell banking. This outreach grows the customer base and fuels interest in stem cell research and regenerative medicine. Additionally, their international presence and ability to provide cross-border services amplify market reach and accessibility, further driving growth.

The report has provided a comprehensive analysis of the competitive landscape in the stem cell banking market. Detailed profiles of all major companies have also been provided.

  • CBR Systems Inc.
  • China Cord Blood Corporation
  • Cordlife
  • Cordvida
  • Cryo-Cell International, Inc.
  • Cryo-Save AG (A Group of Esperite)
  • Cryoviva India
  • Lifecell
  • Smart Cells International Ltd
  • Viacord

Key Questions Answered in This Report

  • 1.What was the size of the global stem cell banking market in 2024?
  • 2.What is the expected growth rate of the global stem cell banking market during 2025-2033?
  • 3.What are the key factors driving the global stem cell banking market?
  • 4.What has been the impact of COVID-19 on the global stem cell banking market?
  • 5.What is the breakup of the global stem cell banking market based on the product type?
  • 6.What is the breakup of the global stem cell banking market based on the service type?
  • 7.What is the breakup of the global stem cell banking market based on the bank type?
  • 8.What is the breakup of the global stem cell banking market based on the utilization?
  • 9.What is the breakup of the global stem cell banking market based on the application?
  • 10.What are the key regions in the global stem cell banking market?
  • 11.Who are the key players/companies in the global stem cell banking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Service Type
  • 5.6 Market Breakup by Bank Type
  • 5.7 Market Breakup by Utilization
  • 5.8 Market Breakup by Application
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Adult Stem Cells
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Embryonic Cells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IPS Cells
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Service Type

  • 7.1 Sample Preservation and Storage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sample Analysis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sample Processing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sample Collection and Transportation
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Bank Type

  • 8.1 Private
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Public
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Utilization

  • 9.1 Used
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Unused
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Personalized Banking Applications
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Applications
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Clinical Applications
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Stem Cell Banking Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 CBR Systems Inc.
    • 16.3.2 China Cord Blood Corporation
    • 16.3.3 Cordlife
    • 16.3.4 Cordvida
    • 16.3.5 Cryo-Cell International, Inc.
    • 16.3.6 Cryo-Save AG (A Group of Esperite)
    • 16.3.7 Cryoviva India
    • 16.3.8 Lifecell
    • 16.3.9 Smart Cells International Ltd
    • 16.3.10 Viacord

List of Figures

  • Figure 1: Global: Stem Cell Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Banking Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Stem Cell Banking Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Stem Cell Banking Market: Breakup by Service Type (in %), 2024
  • Figure 5: Global: Stem Cell Banking Market: Breakup by Bank Type (in %), 2024
  • Figure 6: Global: Stem Cell Banking Market: Breakup by Utilization (in %), 2024
  • Figure 7: Global: Stem Cell Banking Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Stem Cell Banking Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Stem Cell Banking Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 10: Global: Stem Cell Banking Industry: SWOT Analysis
  • Figure 11: Global: Stem Cell Banking Industry: Value Chain Analysis
  • Figure 12: Global: Stem Cell Banking Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Stem Cell Banking (Adult Stem Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Stem Cell Banking (Adult Stem Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Stem Cell Banking (Human Embryonic Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Stem Cell Banking (Human Embryonic Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Stem Cell Banking (IPS Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Stem Cell Banking (IPS Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Stem Cell Banking (Sample Preservation and Storage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Stem Cell Banking (Sample Preservation and Storage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Stem Cell Banking (Sample Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Stem Cell Banking (Sample Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Stem Cell Banking (Sample Processing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Stem Cell Banking (Sample Processing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Stem Cell Banking (Sample Collection and Transportation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Stem Cell Banking (Sample Collection and Transportation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Stem Cell Banking (Private) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Stem Cell Banking (Private) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Stem Cell Banking (Public) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Stem Cell Banking (Public) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Stem Cell Banking (Used) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Stem Cell Banking (Used) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Stem Cell Banking (Unused) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Stem Cell Banking (Unused) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Stem Cell Banking (Personalized Banking Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Stem Cell Banking (Personalized Banking Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Stem Cell Banking (Research Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Stem Cell Banking (Research Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Stem Cell Banking (Clinical Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Stem Cell Banking (Clinical Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Stem Cell Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Stem Cell Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Stem Cell Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Stem Cell Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia Pacific: Stem Cell Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia Pacific: Stem Cell Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Middle East and Africa: Stem Cell Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Middle East and Africa: Stem Cell Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Latin America: Stem Cell Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Latin America: Stem Cell Banking Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Stem Cell Banking Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Stem Cell Banking Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Stem Cell Banking Market Forecast: Breakup by Service Type (in Million USD), 2025-2033
  • Table 4: Global: Stem Cell Banking Market Forecast: Breakup by Bank Type (in Million USD), 2025-2033
  • Table 5: Global: Stem Cell Banking Market Forecast: Breakup by Utilization (in Million USD), 2025-2033
  • Table 6: Global: Stem Cell Banking Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 7: Global: Stem Cell Banking Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Stem Cell Banking Market Structure
  • Table 9: Global: Stem Cell Banking Market: Key Players